Effectiveness of autoHYpnosis in the Prevention of Anxiety During Radiotherapy of Head and Neck Tumors (HYMACO) (HYMACO)

  • days left to enroll
  • participants needed
  • sponsor
    Institut de Cancérologie de Lorraine
Updated on 7 April 2022


HYMACO is a monocentric, randomized comparative pilot study with a total duration of 25 months. The purpose of this study is to evaluate the effectiveness of autoHYpnosis by anchoring in the prevention of anxiety related to wearing the mask for radiotherapy of head and neck tumors.

60 patients will be randomized into 3 arms ARM A : Standard care ARM B : Autohypnosis ARM C : Musicotherapy This study is carried out during the first 5 radiotherapy sessions because this is decisive for the good progress of subsequent sessions

Condition Head and Neck Tumors
Treatment Standard Care, musicotherapy, Autohypnosis, Autohypnosis
Clinical Study IdentifierNCT04671485
SponsorInstitut de Cancérologie de Lorraine
Last Modified on7 April 2022


Yes No Not Sure

Inclusion Criteria

Age > or =18
Patient to receive radiotherapy for a tumor of the head and neck, with a compression mask
Patient who obtained a score equal to or greater than 56 on the STAI form Y-A questionnaire during the consultation with the radiotherapist before starting treatment
Patient capable and willing to follow all study procedures in accordance with the protocol
Patient who understood the study and gave informed consent
Patient affiliated to a social security system

Exclusion Criteria

Contraindication to hypnosis: psychosis, schizophrenia
Non-French speaking patient
Significant hearing loss
Pregnant woman, likely to be, or breastfeeding
Persons deprived of their liberty or under guardianship (including guardianship)
Inability to undergo medical monitoring of the trial for geographical, social or psychological reasons
Patient who has already received radiotherapy to the head or neck with a compression mask
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note